Like rock posters, album art, and comix, blotter art played a crucial role in shaping the counterculture experience. The post...
TORONTO, March 26, 2024 (GLOBE NEWSWIRE) — Further to the announcement by Psyence Group Inc (“Psyence” or the “Company“) (CSE:PSYG) of its...
VANCOUVER, British Columbia, March 26, 2024 (GLOBE NEWSWIRE) — Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a leading Health Canada licensed...
PharmAla Biotech Holdings Inc. announced that, through its joint venture, Cortexa Pty. Ltd. (Cortexa), in what is an Australian and the Company believes...
Uncover the hidden history of Indigenous psilocybin mushroom use, from ancient practices to global traditions, in this captivating exploration.
Recent studies have unearthed fascinating insights into how psilocybin, a naturally occurring compound in certain mushroom species—often referred to...
Recent studies have shed light on the intriguing potential of hallucinogenic mushrooms, specifically those containing psilocybin, in offering therapeutic...
MindBio Therapeutics Corp. announced first dosing has begun in a Phase 2B randomised controlled clinical trial microdosing MB22001 in patients with Major...
SARASOTA, FL, March 20, 2024 (GLOBE NEWSWIRE) — Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical...
VANCOUVER, BC, March 20, 2024 /CNW/ – Numinus Wellness Inc. (“Numinus” or the “Company“) (TSX: NUMI) (OTCQX: NUMIF), a mental health care...
Psyence Biomedical Ltd. issued a statement welcoming the results of a recent study finding evidence that nature-derived psilocybin may be demonstrably...
Gilgamesh Pharmaceuticals, located in New York, has recently received a significant financial boost with a $14 million grant from the National Institute...
The firm is trying to advance its lead compound, REL-1017, through late-stage clinical trials. The post Relmada Therapeutics trims losses, slashes research...
Biotech company Seelos Therapeutics, Inc. (Nasdaq: SEEL) told investors on Tuesday that its drug SLS-005 (IV trehalose) failed a study to treat amyotrophic...
The drug aims to be effective like ibogaine but without the heart risks. The post Gilgamesh secures $14M for ibogaine-like drug appeared first on Green...
In a recent digital conversation with ex-CNN host Don Lemon, now shared widely across the internet, Tesla and SpaceX chief Elon Musk candidly discussed...